Zentek Announces Non-Brokered Private Placement of Units for up to $3 Million Guelph, Ontario--(Newsfile Corp. - July 23, 2024) - Zentek Ltd. (NASDAQ: ZTEK) (TSXV: ZEN) ("Zentek" or the "Company"), an intellectual property development and commercialization company is pleased to announce its intention to complete a non-brokered private placement of up to $3 million through the issuance of up to 2,307,692 units (the "Units") in the capital of the Company at a price of $1.30 per Unit (the "Offering").
Zentek Subsidiary Albany Graphite Corp. Achieves Five Nines Purity for Albany Graphite GUELPH, ON / ACCESSWIRE / July 17, 2024 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property technology development and commercialization company is pleased to announce that its wholly owned subsidiary, Albany Graphite Corporation (AGC) has achieved a five nines purity of 99.99915% for a graphite sample from the Albany graphite deposit.
ZTEK Stock Earnings: Zentek Reported Results for Q4 2024 Zentek (NASDAQ: ZTEK ) just reported results for the fourth quarter of 2024. Zentek reported earnings per share of -2 cents. The company reported revenue of $4.23 million. InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com. More From InvestorPlace The #1 AI Investment Might Be This Company You’ve Never Heard Of Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In. Legendary Investor Predicts: “Forget A.I. THIS Technology Is the Future” The post ZTEK Stock Earnings: Zentek Reported Results for Q4 2024 appeared first on InvestorPlace .
Zentek Rewards Team with Stock Options Incentive Zentek (TSE:ZEN) has released an update. Zentek Ltd., a technology company specializing in novel antimicrobial and air filtration solutions, has gr…
Zentek Announces Grant of Stock Options GUELPH, ON / ACCESSWIRE / June 21, 2024 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN) announces the granting of options to acquire an aggregate of 1,935,000 common shares to certain directors, officers and employees of the Company, exercisable at a price of $1.52 per common share for a period of five years from the date of the grant.
Zentek Secures Patent for Antimicrobial Agent Zentek (TSE:ZEN) has released an update. Zentek Ltd. has been granted a second patent from the Canadian Intellectual Property Office for a graphene…
Zentek Ltd.: Zentek and DCL Supply Ltd. Sign Distribution Agreement for ZenGUARD Enhanced Air Filters GUELPH, ON / ACCESSWIRE / May 23, 2024 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company and DCL Supply Ltd. ("D…
Zentek Finds HVAC Savings for Toronto Zentek Ltd. (TSE:ZEN) has released an update. Zentek Ltd. has concluded a case study demonstrating that the City of Toronto could save over $40 mil…
Zentek Completes Case Study on HVAC Total Cost of Ownership Savings for the City of Toronto GUELPH, ON / ACCESSWIRE / May 7, 2024 / Zentek Ltd. (" Zentek " or the " Company ") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company is pleased to announce that it has completed a case study based on the City of Toronto highlighting the economic and environmental benefits related to using MERV 9A filters compared to using MERV 13 filters.
Zentek subsidiary achieves positive results against H5N1 using multivalent aptamer technology Zentek''s subsidiary, Triera Biosciences, reports positive initial test results for avian influenza H5N1 therapy, utilizing a universal aptamer.